Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Detail Textuals)

v3.19.1
Subsequent Events (Detail Textuals) - USD ($)
 1 Months Ended 12 Months Ended
Feb. 28, 2019
Feb. 01, 2019
Jan. 31, 2019
Dec. 31, 2017
Subsequent Event [Line Items]        
Value of warrants issued       $ 145,200
Subsequent Event | Pharmaceuticals International, Inc. Agreement        
Subsequent Event [Line Items]        
Estimated initial payment for contract     $ 72,500  
Subsequent Event | RRD International Agreement        
Subsequent Event [Line Items]        
Amount of payments due under the contract     78,680  
Amount of pass through expenses and consulting fees     $ 22,000  
Subsequent Event | 2nd Draw on Multi Draw Credit Facility        
Subsequent Event [Line Items]        
Value of warrants issued   $ 2,000,000    
Number of warrants issued   2,500,000    
Warrant exercise price   $ 0.50    
Subsequent Event | Noramco Agreement        
Subsequent Event [Line Items]        
Upfront payment $ 146,386